SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028046
Filing Date
2023-08-14
Accepted
2023-08-14 08:00:50
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 586706
2 ex31-1.htm EX-31.1 11854
3 ex31-2.htm EX-31.2 11888
4 ex31-3.htm EX-31.3 11847
5 ex32-1.htm EX-32.1 10017
  Complete submission text file 0001493152-23-028046.txt   3871632

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cocp-20230630.xsd EX-101.SCH 34101
7 XBRL CALCULATION FILE cocp-20230630_cal.xml EX-101.CAL 43353
8 XBRL DEFINITION FILE cocp-20230630_def.xml EX-101.DEF 144713
9 XBRL LABEL FILE cocp-20230630_lab.xml EX-101.LAB 295009
10 XBRL PRESENTATION FILE cocp-20230630_pre.xml EX-101.PRE 231457
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 482789
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 231166401
SIC: 2834 Pharmaceutical Preparations